Clovis nkag mus rau kev lag luam nrog Deal muag Cancer-Drug Candidate rau Novartis

Clovis Oncology Inc., tus tsim tshuaj ntawm zes qe menyuam thiab prostate mob qog noj ntshav Rubraca, tau foob rau kev lag luam poob rau lub asthiv nrog rau kev pom zoo hauv tes los muag nws cov cai rau kev kho mob qog noj ntshav hauv kev txhim kho ...

Cancer Focused Clovis Oncology Files For Bankruptcy

Clovis Oncology Inc (NASDAQ: CLVS) tau yeem pib ua Tshooj 11 ua haujlwm hauv US Tsev Hais Plaub Ntug Nyiaj Txiag thiab yuav nrhiav kev muag nws cov cuab tam los ntawm lub tsev hais plaub saib xyuas cov txheej txheem muag khoom. Cov Debtors...

Clovis Oncology Tshuag swb 10% ua ntej muag tom qab tuam txhab cov ntaub ntawv rau kev lag luam

Clovis Oncology Inc. Tshuag CLVS, +19.83% poob 10% hauv kev lag luam ua ntej hnub Monday, tom qab biotech tau thov rau Tshooj 11 kev lag luam thiab hais tias nws yuav muag cov khoom muaj nqis. Lub tuam txhab muaj kev cog lus rau txog $ 75 ...

Clovis Oncology Tshuag swb 75% tom qab biotech ceeb toom nws yuav tag nrho cov nyiaj ntsuab los ntawm Lub Ib Hlis Ntuj xyoo 2023

Clovis Oncology Inc. shares CLVS, -71.62% plunged 75% Wednesday, tom qab Colorado-based biotech hais tias nws yuav tsis muaj peev txheej txaus los tswj kev ua haujlwm dhau lub Ib Hlis xyoo 2023. Lub tuam txhab ...